This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Innopharmax, Inc., Tsh Biopharm Corporation Ltd.. Active years: 2014.
Company Filing History:
1 out of 5 
1 out of 2 Years Active: 2014
Title: Ta-Chien Lu: Innovator in Controlled Release Formulations
Introduction
Ta-Chien Lu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of controlled release medications. His innovative work aims to improve patient compliance and therapeutic outcomes.
Latest Patents
One of Ta-Chien Lu's key patents is a controlled release carvedilol formulation. This formulation is designed for less frequent, preferably once daily administration. It comprises a therapeutically effective amount of carvedilol or a pharmaceutically acceptable salt thereof, a matrix forming polymer, a solubility enhancer, and a pharmaceutically acceptable carrier. In one embodiment, the formulation contains two or more subunits with different release profiles, making it effective in treating cardiovascular disorders.
Career Highlights
Throughout his career, Ta-Chien Lu has worked with prominent companies in the pharmaceutical industry, including Tsh Biopharm Corporation Ltd. and Innopharmax, Inc. His expertise in drug formulation has positioned him as a valuable asset in the development of innovative therapeutic solutions.
Collaborations
Ta-Chien Lu has collaborated with several professionals in his field, including Wei-Hua Hao and Tsung-Hsin Lin. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.
Conclusion
Ta-Chien Lu's contributions to controlled release formulations highlight his commitment to improving healthcare through innovation. His work continues to influence the pharmaceutical industry and enhance patient care.